Rethinking Ablative Risks and Results: Physics That Changed the Treatment Equation

In this session, renowned dermatologist Cheryl Burgess, MD will challenge the conventional risk-benefit analysis of epidermal resurfacing. You'll discover why wavelength selection, pulse architecture, and thermal confinement fundamentally change what's possible in Fitzpatrick IV-VI skin—and why the old "ablative = high PIH risk" equation no longer holds weight when you understand the physics.

This isn't a sales pitch for "safe for all skin types." It's a clinical deep-dive into why Er:YAG's 2940nm wavelength, 300-microsecond pulse delivery, and controlled ablation depth allow you to resurface skin that CO₂ couldn't touch without the prolonged erythema, PIH, or patient anxiety.

Key Topics:

• Why traditional ablative resurfacing comes with challenges in darker skin—and what's actually different now.
• The physics behind wavelength-specific water absorption and why it matters for melanocyte protection.
• How microsecond pulse control minimizes lateral thermal damage and PIH risk.
• Real treatment protocols Dr. Burgess uses for texture, photoaging, and acne scarring across skin tones.

‍

Register to watch this webinar live on February 18, 2026 at 8:00pm EST!

‍

Presented by Cheryl Burgess, MD, FAAD

Founder, medical director, and president of the Center for Dermatology and Dermatologic Surgery, PC in Washington, DC. Dr. Burgess is a nationally and internationally recognized expert for advanced technology in non-invasive aesthetic procedures. Currently serving on the Board of Directors for the American Academy of Dermatology.